Related Experiment Video
Updated: Feb 15, 2026

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
Published on: January 22, 2011
[Update in Surgical Oncology]
Daniel Clerc1, Didier Roulin1, Nicolas Demartines1
1Service de chirurgie viscérale, CHUV, 1011 Lausanne.
Abstract:
In 2017, data from large multicentre randomized controlled trials assessed the safety of minimally invasive techniques for liver or esophagus resection with similar oncologic outcome compared to open approach. Patients also benefit from progress in medical oncology in particular with the development of new targeted therapies, offering surgery to patients with initially non-resectable disease. The increase in complete tumor response after neoadjuvant treatment allows more conservative approaches, like organ preserving surgery for rectal cancer. The constant improvement in perioperative care and enhanced recovery programs (Enhanced Recovery After Surgery - ERAS) reduce both length of hospital stay and costs, decrease the risk of postoperative complications, and offer better quality of life to the patients.
Insights
Minimally invasive surgery for liver and esophageal cancer shows similar outcomes to open surgery. Advances in cancer therapies and perioperative care improve patient quality of life and reduce hospital stays.
Area of Science:
- Surgical Oncology
- Medical Oncology
- Perioperative Care
Background:
- Large multicentre randomized controlled trials (2017) evaluated minimally invasive techniques for liver and esophagus resection.
- Progress in targeted therapies offers surgical options for initially non-resectable cancers.
- Increased tumor response to neoadjuvant treatment enables organ-preserving surgery for rectal cancer.
Purpose of the Study:
- To assess the safety and oncologic outcomes of minimally invasive surgical techniques compared to open surgery.
- To highlight the impact of advancements in medical oncology and perioperative care on surgical patient management.
- To demonstrate the benefits of enhanced recovery programs on patient outcomes and healthcare costs.
Main Methods:
- Analysis of data from large multicentre randomized controlled trials.
- Review of advancements in targeted therapies and neoadjuvant treatment protocols.
- Evaluation of the impact of Enhanced Recovery After Surgery (ERAS) programs.
Main Results:
- Minimally invasive liver and esophagus resection demonstrated similar oncologic outcomes to open approaches.
- Targeted therapies have expanded surgical eligibility for patients with advanced disease.
- Enhanced Recovery After Surgery (ERAS) programs significantly reduce hospital stay, costs, and postoperative complications.
Conclusions:
- Minimally invasive surgical techniques are safe and effective for liver and esophagus resection.
- Multidisciplinary cancer treatment, including medical oncology and surgical advancements, improves patient prognosis.
- Optimized perioperative care and ERAS protocols enhance patient recovery and quality of life.
More Related Videos
06:37Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology
Published on: October 20, 2010
06:05The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Urinary Tract Calculi VI: Surgical Management
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Schemas